Weiwei Huang
- Molecular Biology top 10%
- Cancer Research top 5%
- Microbiology top 1%
- Epidemiology top 10%
- Immunology top 10%
- Topics
- Immunotherapy and Immune Responses (10 papers)Cancer-related molecular mechanisms research (8 papers)Bacterial Infections and Vaccines (7 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Weiwei Huang
73 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 118
- Molecular Biology 1.2k
- Cancer Research 464
- Microbiology 448
- Epidemiology 427
- Immunology 376
Countries citing papers authored by Weiwei Huang
This map shows the geographic impact of Weiwei Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Huang more than expected).
Fields of papers citing papers by Weiwei Huang
This network shows the impact of papers produced by Weiwei Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Huang. The network helps show where Weiwei Huang may publish in the future.
Co-authorship network of co-authors of Weiwei Huang
This figure shows the co-authorship network connecting the top 25 collaborators of Weiwei Huang. A scholar is included among the top collaborators of Weiwei Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiwei Huang. Weiwei Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 13 | |
| 3 | 79 | |
| 4 | 72 | |
| 5 | 19 | |
| 6 | 11 | |
| 7 | 27 | |
| 8 | 18 | |
| 9 | 29 | |
| 10 | 27 | |
| 11 | 18 | |
| 12 | 17 | |
| 13 | 63 | |
| 14 | 18 | |
| 15 | 11 | |
| 16 | 77 | |
| 17 | 4 | |
| 18 | 35 | |
| 19 | 85 | |
| 20 | 203 |
About Weiwei Huang
Weiwei Huang is a scholar working on Microbiology, Immunology and Molecular Medicine, having authored 76 papers that have together received 2.4k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (10 papers), Cancer-related molecular mechanisms research (8 papers) and Bacterial Infections and Vaccines (7 papers). The work is most often cited by research in Microbiology (448 citations), Molecular Medicine (266 citations) and Endocrinology (192 citations). Weiwei Huang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Yanbing Ma, Wenjia Sun, Cunbao Liu, Hongmei Bai, Xu Yang, Liangqun Hua, Qiong Long, Yufeng Yao, Yang Li and Paul D. Cao. Their work appears in journals such as Nucleic Acids Research, Advanced Materials and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.